Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06595420 · ClinicalTrials.gov registry record
Kidney Function in People With Cystic Fibrosis in the Era of HEMT
A clinical trial of Acute Kidney Injury and Cystic Fibrosis (CF), sponsored by University of Virginia.
- Recruiting
- Registry status
- 260
- Enrollment target
- 3
- Study locations
NCT06595420 is a study of Acute Kidney Injury and Cystic Fibrosis (CF) that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 260 participants, below the 2,327-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06595420, a study of Acute Kidney Injury and Cystic Fibrosis (CF), is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- 260 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to find out what causes kidney disease in people with CF. The investigators will study biomarkers in the blood and urine that can either predict who is at risk or detect kidney damage early before it becomes permanent. The study will compare these markers in people with CF over time and during the treatment of lung flare-ups. It will also compare the blood and urine samples obtained from people without CF. The comparison aims to better understand the impact of cystic fibrosis and its treatment on the kidneys, as well as to develop improved methods for preventing, diagnosing, and treating kidney issues associated with CF.
Conditions Studied
Study Locations (3)
Alabama
- University of Alabama at Birmingham - Birmingham
New Hampshire
- Dartmouth-Hitchcock Geisel School of Medicine at Dartmouth - Lebanon
Virginia
- University of Virginia Children's Hospital - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2025-01-09 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06595420
The ClinicalTrials.gov registry entry for NCT06595420 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,327-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (89% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 0 interventions.
NCT06595420 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Alabama, New Hampshire, Virginia.
Frequently Asked Questions
What is clinical trial NCT06595420 about?
NCT06595420 is a clinical study titled "Kidney Function in People With Cystic Fibrosis in the Era of HEMT". The purpose of this study is to find out what causes kidney disease in people with CF. The investigators will study biomarkers in the blood and urine that can either predict who is at risk or detect kidney damage early before it becomes permanent. The study will compare these markers in people with ...
What is the current status of trial NCT06595420?
This trial is currently recruiting. The enrollment target is 260 participants. The study started on 2025-01-09. Estimated completion is 2027-12.
What conditions does trial NCT06595420 study?
This clinical trial studies the following conditions: Acute Kidney Injury, Cystic Fibrosis (CF), Chronic Kidney Disease(CKD).
Who is sponsoring clinical trial NCT06595420?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06595420 being conducted?
This trial has 3 study locations across Alabama, New Hampshire, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.